Data as of Mar 07
| -0.02 / -0.58%|
The 5 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 3.50. The median estimate represents a +17.30% increase from the last price of 3.41.
The current consensus among 8 polled investment analysts is to Hold stock in Achillion Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.